FindTrial
Sign In

Prediction of pregnancy induced hypertension by maternal serum beta hCG levels in second trimester

The efficacy of second - trimester serum beta HCG levels in the prediction of pregnancy induced hypertension: A Prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046257
Enrollment
162
Registered
2022-10-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O132- Gestational [pregnancy-induced] hypertension without significant proteinuria, second trimester

Interventions

None listed

Sponsors

BLDEDU Shri BM Patil Medical College Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: primigravidae/multigravidae with singleton pregnancy with gestational age of 16 weeks to 20 weeks who are previously normotensive.

Exclusion criteria

Exclusion criteria: chronic hypertension gestational diabetes milletus multiple pregnancies antenatal women with congenital anomalies gestational trophoblastic diseases

Design outcomes

Primary

MeasureTime frame
PREDICTION OF PREGNANCY INDUCED HYPERTENSION BY MATERNAL SERUM BETA HCG LEVELS IN SECOND TRIMESTERTimepoint: Base line bp recorded and beta Hcg sample taken between 16weeks - 20weeks followed by every 4 weeks till 28weeks then fortnightly till 34 weeks followed by weekly till the time of delivery—

Secondary

MeasureTime frame
to evaluate cause of pregnancy induced hypertensionTimepoint: 20 weeks - 24 weeks—

Countries

India

Contacts

Public ContactDr Vishnu Priya

BLDE(DU) Shri BM Patil Medical College Hospital and Research Centre

obg@bldedu.ac.in9880162550

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026